Home > Insider Trading > Filing (0001209191-20-037483)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1510487	Principia Biopharma Inc.	PRNB	Pharmaceutical Preparations (2834)	263487603

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1751790	Stefani Wolff	C/O Principia Biopharma Inc. 220 E. Grand Avenue South San Francisco CA 94080	Chief Development Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2019-12-16	4,205	$49.29	31,404	No	4	S	Direct
Common Stock	Disposition	2019-12-16	1,300	$49.87	30,104	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Footnotes

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
Represents the weighted average sales price per share. The shares sold at prices ranging from $48.81 to $49.725 per share. Upon request by the Commission staff, Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
Includes 2,500 shares and 441 shares acquired under the Employment Stock Purchase Plan on May 15, 2019 and November 15, 2019 respectively.
Due to administrative error, stock options were incorrectly reported as exercised on the original Form 4 filed on December 18, 2019, pursuant to a 10b5-1 transaction. That original Form 4 is hereby amended in its entirety.
Represents the weighted average sales price per share. The shares sold at prices ranging from $49.855 to $49.87 per share. Upon request by the Commission staff, Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.